 Laurence Chan
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 10 | 2015 | 538 | 1.230 |
Why?
| | Immunosuppressive Agents | 9 | 2015 | 641 | 0.900 |
Why?
| | Graft Rejection | 8 | 2015 | 511 | 0.880 |
Why?
| | Isoantibodies | 5 | 2014 | 52 | 0.850 |
Why?
| | Tacrolimus | 3 | 2015 | 134 | 0.720 |
Why?
| | Sirolimus | 3 | 2010 | 181 | 0.670 |
Why?
| | Boronic Acids | 2 | 2010 | 33 | 0.650 |
Why?
| | Pyrazines | 2 | 2010 | 71 | 0.630 |
Why?
| | Pancreas Transplantation | 4 | 2011 | 61 | 0.540 |
Why?
| | HLA Antigens | 4 | 2011 | 220 | 0.540 |
Why?
| | Graft Survival | 5 | 2014 | 443 | 0.500 |
Why?
| | Kidney Failure, Chronic | 2 | 2010 | 489 | 0.450 |
Why?
| | Sphingosine | 1 | 2012 | 33 | 0.400 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 128 | 0.390 |
Why?
| | Immunologic Factors | 1 | 2012 | 217 | 0.340 |
Why?
| | Reperfusion Injury | 1 | 2012 | 252 | 0.330 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2012 | 337 | 0.330 |
Why?
| | Protease Inhibitors | 1 | 2010 | 96 | 0.320 |
Why?
| | Ischemia | 1 | 2012 | 361 | 0.320 |
Why?
| | Transplantation, Homologous | 2 | 2011 | 377 | 0.310 |
Why?
| | Kidney Medulla | 1 | 2008 | 29 | 0.300 |
Why?
| | Kidney Tubules, Collecting | 1 | 2008 | 25 | 0.300 |
Why?
| | Kidney | 2 | 2012 | 1182 | 0.300 |
Why?
| | Enzymes | 1 | 2008 | 62 | 0.290 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 637 | 0.250 |
Why?
| | Tissue Donors | 4 | 2011 | 314 | 0.230 |
Why?
| | Energy Metabolism | 1 | 2008 | 727 | 0.210 |
Why?
| | Histocompatibility | 2 | 2014 | 26 | 0.210 |
Why?
| | Proteomics | 1 | 2008 | 815 | 0.200 |
Why?
| | Immunoglobulins, Intravenous | 2 | 2014 | 122 | 0.180 |
Why?
| | Bortezomib | 2 | 2010 | 41 | 0.160 |
Why?
| | Everolimus | 2 | 2010 | 61 | 0.160 |
Why?
| | Living Donors | 2 | 2010 | 270 | 0.140 |
Why?
| | Drug Therapy, Combination | 2 | 2010 | 949 | 0.130 |
Why?
| | Biopsy | 2 | 2010 | 1024 | 0.130 |
Why?
| | Tremor | 1 | 2015 | 45 | 0.120 |
Why?
| | Time Factors | 7 | 2014 | 6077 | 0.100 |
Why?
| | Middle Aged | 7 | 2015 | 26605 | 0.100 |
Why?
| | Male | 10 | 2015 | 55396 | 0.090 |
Why?
| | Creatinine | 2 | 2011 | 424 | 0.090 |
Why?
| | Proteasome Inhibitors | 1 | 2010 | 41 | 0.080 |
Why?
| | Antilymphocyte Serum | 1 | 2009 | 60 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2010 | 133 | 0.080 |
Why?
| | Antibodies | 1 | 2011 | 365 | 0.080 |
Why?
| | Cadaver | 1 | 2010 | 298 | 0.080 |
Why?
| | Immunity, Humoral | 1 | 2010 | 112 | 0.080 |
Why?
| | Osmotic Pressure | 1 | 2008 | 28 | 0.080 |
Why?
| | Cyclosporine | 1 | 2009 | 161 | 0.080 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 99 | 0.080 |
Why?
| | Chronic Disease | 2 | 2014 | 1577 | 0.080 |
Why?
| | Saline Solution, Hypertonic | 1 | 2008 | 39 | 0.070 |
Why?
| | Adult | 6 | 2015 | 30375 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2015 | 9049 | 0.070 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2008 | 134 | 0.070 |
Why?
| | Phosphates | 1 | 2008 | 155 | 0.070 |
Why?
| | Female | 8 | 2015 | 59325 | 0.070 |
Why?
| | Young Adult | 3 | 2015 | 10444 | 0.070 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2008 | 238 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 924 | 0.060 |
Why?
| | Blotting, Western | 1 | 2008 | 1143 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2015 | 2122 | 0.060 |
Why?
| | Amino Acids | 1 | 2008 | 445 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 484 | 0.060 |
Why?
| | Polymers | 1 | 2008 | 448 | 0.060 |
Why?
| | Glucose | 1 | 2008 | 899 | 0.050 |
Why?
| | Mitochondria | 1 | 2008 | 744 | 0.050 |
Why?
| | Cell Line | 1 | 2008 | 2629 | 0.050 |
Why?
| | Humans | 9 | 2015 | 114043 | 0.050 |
Why?
| | Animals | 4 | 2012 | 31565 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2008 | 2173 | 0.050 |
Why?
| | Phenotype | 1 | 2008 | 2784 | 0.040 |
Why?
| | Acute Disease | 2 | 2014 | 907 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2011 | 813 | 0.040 |
Why?
| | Glomerular Filtration Rate | 2 | 2011 | 605 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 273 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 158 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2015 | 714 | 0.030 |
Why?
| | Patient Selection | 2 | 2009 | 629 | 0.030 |
Why?
| | Prospective Studies | 2 | 2015 | 6195 | 0.020 |
Why?
| | Mice | 1 | 2008 | 14841 | 0.020 |
Why?
| | Colorado | 2 | 2011 | 4090 | 0.020 |
Why?
| | Retrospective Studies | 3 | 2014 | 12521 | 0.020 |
Why?
| | Monitoring, Immunologic | 1 | 2011 | 23 | 0.020 |
Why?
| | Transplantation Tolerance | 1 | 2011 | 30 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2011 | 115 | 0.020 |
Why?
| | HLA-D Antigens | 1 | 2009 | 34 | 0.020 |
Why?
| | Prostaglandins A | 1 | 2009 | 8 | 0.020 |
Why?
| | Urinalysis | 1 | 2009 | 64 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 768 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2009 | 170 | 0.020 |
Why?
| | Rabbits | 1 | 2009 | 733 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2009 | 368 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1075 | 0.020 |
Why?
| | Reoperation | 1 | 2009 | 513 | 0.020 |
Why?
| | Risk | 1 | 2009 | 810 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2009 | 474 | 0.020 |
Why?
| | Survivors | 1 | 2009 | 412 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1791 | 0.020 |
Why?
| | Survival Rate | 1 | 2009 | 1638 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 1836 | 0.020 |
Why?
| | Mass Screening | 1 | 2011 | 979 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 6306 | 0.010 |
Why?
| | Patient Discharge | 1 | 2009 | 770 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2009 | 1068 | 0.010 |
Why?
| | Risk Assessment | 1 | 2011 | 2958 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2009 | 4392 | 0.010 |
Why?
| | Rats | 1 | 2009 | 4913 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 3397 | 0.010 |
Why?
| | Risk Factors | 1 | 2011 | 8614 | 0.010 |
Why?
| | Aged | 1 | 2015 | 18969 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 17800 | 0.010 |
Why?
|
|
Chan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|